CASR and nephrolithiasis: Notably, we observed low urinary oxalate in our rat nephrolithiasis model treated with GdCl3 compared with group B; one possible explanation for this finding is that CaSR increased free calcium, which binds to oxalate and thus reduces urinary oxalate.